Jyong Biotech Ltd. (MENS) Ownership
MENS ownership summary
as of October 18, 2026- Institutions
- 0.8% of shares outstanding
- Insiders
- 62.20% of shares outstanding
- Shares outstanding
- 74.2M
- Float
- 26.9M shares available to trade
- Short interest
- 0.54% 222K shares short
- Days to cover
- 4.35 short interest down 9.5% vs prior month
- Institutions 0.77%
- Insiders 62.20%
- Other investors 37.03%
MENS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 0.35% | 260K | $478,983 | +1,557 (+0.6%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.09% | 69K | $126,743 | +4,650 (+7.2%) | June 30, 2026 |
| 3 | HRT FINANCIAL LLC | 0.07% | 50K | $92,778 | +38,656 (+328.5%) | June 30, 2026 |
| 4 | XTX Topco Ltd | 0.04% | 29K | $53,481 | +29,066 (0.0%) | June 30, 2026 |
| 5 | Renaissance Technologies Corp | 0.03% | 23K | $42,136 | +22,900 (0.0%) | June 30, 2026 |
| 6 | China Universal Asset Mgmt Co.Ltd | 0.02% | 12K | $22,264 | −1,073 (−8.1%) | June 30, 2026 |
| 7 | State of Wyoming | 0.02% | 11K | $20,623 | +11,208 (0.0%) | June 30, 2026 |
| 8 | Morgan Stanley - Brokerage Accounts | 0.01% | 6,112 | $11,246 | −189 (−3.0%) | June 30, 2026 |
| 9 | Barclays PLC | 0.01% | 5,931 | $10,913 | +742 (+14.3%) | June 30, 2026 |
| 10 | JPMorgan Chase & Co | 0.01% | 5,379 | $9,897 | −300 (−5.3%) | June 30, 2026 |
| 11 | UBS Group AG | 0.01% | 4,046 | $7,445 | −33,317 (−89.2%) | June 30, 2026 |
| 12 | Mirae Asset Global Investments (Korea) Co Ltd | <0.01% | 3,400 | $6,256 | −472 (−12.2%) | June 30, 2026 |
| 13 | BNP Paribas Arbitrage, SA | <0.01% | 2,710 | $4,986 | +829 (+44.1%) | June 30, 2026 |
| 14 | Citigroup Inc | <0.01% | 2,501 | $4,602 | −286 (−10.3%) | June 30, 2026 |
| 15 | Tower Research Capital LLC | <0.01% | 1,070 | $1,969 | −10,633 (−90.9%) | June 30, 2026 |
| 16 | Cornerstone Financial Management, LLC | <0.01% | 234 | $431 | +234 (0.0%) | June 30, 2026 |
| 17 | Bell Investment Advisors, Inc | <0.01% | 206 | $379 | −267 (−56.4%) | June 30, 2026 |
| 18 | Caitong International Asset Management Co., Limited. | 0.00% | 9 | $17 | +9 (0.0%) | June 30, 2026 |
| 19 | Jane Street Group LLC | 0.00% | — | — | −69,560 (−100.0%) | March 31, 2026 |
| 20 | JustInvest LLC | 0.00% | — | — | −13,927 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 110K shares and 10 cut 130K.
MENS top mutual fund and ETF holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Biotechnology ETF | 0.31% | 227K | $417,145 | −1,720 (−0.8%) | September 30, 2026 |
| 2 | iShares Nasdaq US Biotech ETF USD Acc | 0.08% | 57K | $105,642 | +496 (+0.9%) | September 30, 2026 |
| 3 | Fidelity Nasdaq Composite Index | 0.06% | 47K | $85,952 | — | August 31, 2026 |
| 4 | Fidelity Nasdaq Composite ETF | 0.04% | 27K | $49,119 | — | September 30, 2026 |
| 5 | China Universal NASDAQ Bio-Tch ETF(QDII) | 0.02% | 12K | $22,264 | −289 (−2.3%) | June 30, 2026 |
| 6 | Invesco Nasdaq Biotechnology ETF | 0.01% | 5,282 | $9,719 | +238 (+4.7%) | September 30, 2026 |
| 7 | ProShares Ultra Nasdaq Biotechnology | <0.01% | 2,635 | $4,848 | — | September 30, 2026 |
| 8 | GF NASDAQ Bio-Tech Idx QDII USD A | <0.01% | 1,559 | $2,869 | +66 (+4.4%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
MENS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns MENS
Institutional investors own 0.8% of Jyong Biotech's shares and insiders 62.20%. The largest holder is BlackRock Inc with 0.35% of the shares (260K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 10 reduced their stake in the latest filings. Short interest is 0.54% of the float, or 4.35 days of average trading volume. The share count rose 103,578.4% since 2023.
Related: MENS key metrics. See the MENS stock overview for the latest quote and news.
MENS ownership FAQ
Who owns the most Jyong Biotech stock?
The largest shareholders of Jyong Biotech are BlackRock Inc (0.35%), Geode Capital Management, LLC (0.09%), HRT FINANCIAL LLC (0.07%), XTX Topco Ltd (0.04%), Renaissance Technologies Corp (0.03%).
What percentage of Jyong Biotech is owned by institutions?
Institutions hold 0.8% of Jyong Biotech's shares outstanding; insiders hold 62.20%.
Which funds own Jyong Biotech?
The largest fund holders of Jyong Biotech are iShares Biotechnology ETF (0.31%), iShares Nasdaq US Biotech ETF USD Acc (0.08%), Fidelity Nasdaq Composite Index (0.06%), Fidelity Nasdaq Composite ETF (0.04%), China Universal NASDAQ Bio-Tch ETF(QDII) (0.02%).
What is Jyong Biotech's short interest?
222K shares of Jyong Biotech were sold short, 0.54% of the float; at the average daily volume it would take 4.35 days to cover.
How many shares of Jyong Biotech are outstanding?
Jyong Biotech has 74.2M shares outstanding, of which 26.9M are in the public float.